President Donald Trump is going after Tylenol because he and his administration are linking the use of acetaminophen, the active ingredient in Tylenol, during pregnancy to an increased risk of autism in children. Trump has publicly stated that Tylenol use by pregnant women may be a "significant factor" in the rise of autism and the administration has recommended that pregnant women limit their use of Tylenol unless medically necessary, such as for high fever. They have also indicated that the FDA will notify physicians and update the product's labeling to reflect these concerns. This position contradicts the prevailing scientific consensus, which finds no conclusive evidence tying acetaminophen use during pregnancy to autism and maintains that acetaminophen is the safest painkiller for pregnant women. The move comes alongside the Trump administration’s broader efforts to challenge established scientific findings on various health topics and propose alternative treatments for autism, such as leucovorin, a form of folate.
